35 results on '"Sarri, G."'
Search Results
2. RWD106 The Maze of RWE Frameworks: An Environmental Scanning and Comparison Across Regulatory and HTA Bodies
3. HTA241 Health Equity and the Health Technology Assessment Process: Are Children and Young People Being Overlooked? A Review of Pediatric National Institute of Health and Care Excellence Technology Appraisals
4. RWD141 How Global Datasets Can Shed Light on Health Inequalities: An Environmental Scan of Publicly Available Sources
5. HTA119 Mapping a Path to Standardized Evidence Quality Tools Across EU HTA Agencies and NICE: Is EU Joint Clinical Assessment Guidance Falling Behind?
6. CO133 Systematic Literature Review (SLR) of Clinical Data from First-Line Treatment or First-Line Maintenance Therapy for Advanced or Metastatic Ovarian Cancer (2010–2023)
7. HTA199 The Reality of Living Systematic Literature Reviews to Support Timely Healthcare Decisions: A Case Study in Relapsed/Refractory Multiple Myeloma
8. HTA35 Should Health Technology Assessment (HTA) Bodies Utilize Living HTA Tools? Validation of LiveSLR® and LiveNMA™ Tools Using ICER’S Class Review in Relapsed Refractory Multiple Myeloma (RRMM)
9. HTA1 Accounting for Placebo Effects in NICE Technology Appraisals of Biologic Therapies: A Comprehensive Review and Future Recommendations
10. MT16 Jumping Through Hoops: Critical Considerations on Current Draft Reimbursement Guidance for Medical Devices
11. SA80 Data Extraction Templates in Systematic Literature Reviews: How Systematic Are We?
12. HPR4 ISPOR HEOR Trends Over Time: What Is the Influence of Macro HTA Changes?
13. HTA171 Are Global Trials Good Enough to Support the Reimbursement of a New Technology in Asia? A Review of Asian HTA Submissions
14. SA45 Practical Considerations for Developing PICO Statements for Humanistic Burden Reviews: How to Get It Right
15. HTA51 Unravelling the Rationale for the Source of External Control Arm in Single-Arm Oncology Submissions: What Is the Justification behind the Maze of Options?
16. MT16 Unravelling the Puzzle for Medical Devices: What Is Next for Industry?
17. HPR100 Health Technologies Value Assessment Through the Lens of Health Equity; How Far From Being Incorporated Routinely? An Environmental Scan of Health Equity Frameworks and Policy Gaps
18. POSA268 Economic and Humanistic Impact of Vasospasm-Related Complications Following Aneurysmal Subarachnoid Hemorrhage; Results of a Systematic Literature Review
19. MSR44 Non-Randomized Studies in Comparative Effectiveness Research; How Systematically Are They Identified By Existing Search Filters? Results from a Systematic Literature Review
20. HTA63 The Data Lifecycle: Towards a Standardized Relational Data Model to Support Living Systematic Literature Reviews? – Use Case Demonstration with LiveSLR®
21. EE217 Efficiency-Equity Trade-Offs in Cost-Effectiveness Analyses: An Umbrella Review of Previous Systematic Literature Reviews
22. EE216 Which Modelling Methods Can Account for Additional Value Elements in HTAs? Results from a Pragmatic Review
23. PCN130 Modeling Approaches in Cost-Effectiveness Analysis (CEA) of First-Line (1L) Immuno-Oncology (IO) Therapies in Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)
24. PNS221 Healthcare Decision-Making Using Real-World Evidence: Many Opportunities, Little Guidance. Results from a Systematic Review of Guidance
25. PNS156 Are Surrogate Outcomes Enough for the Reimbursement of Health Technologies? An Umbrella Literature Review
26. PCN116 Economic Impact of First-Line (1L) Immunotherapies in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)
27. PNS32 AUTOMATIC ABSTRACT SCREENING USING MACHINE LEARNING TECHNIQUES: ARE WE THERE YET AND HOW CAN WE MOVE FORWARD?
28. PND93 WHAT GOOD ARE DIGITAL TECHNOLOGIES IN ALZHEIMER'S DISEASE RESEARCH? - A SYSTEMATIC LITERATURE REVIEW
29. PHP315 - HOW FREQUENTLY IS PATIENT EXPERIENCE FORMALLY ASSESSED IN HEALTH TECHNOLOGY ASSESSMENTS? RESULTS FROM A SYSTEMATIC LITERATURE REVIEW
30. PCP45 - THE ROLE OF CROSSOVER AND TREATMENT SWITCHING IN INDIRECT TREATMENT COMPARSON IN IMMUNO-ONCOLOGY
31. What's the Reality of Real-World Evidence in Health Technology Appraisal?
32. A Systematic Literature Review of Uk Epidemiology of Brca1 And BRCA2-Mutated Locally Advanced or Metastatic Ovarian Cancer
33. PCN46 - A Systematic Literature Review of Uk Epidemiology of Brca1 And BRCA2-Mutated Locally Advanced or Metastatic Ovarian Cancer
34. PRM235 - What's the Reality of Real-World Evidence in Health Technology Appraisal?
35. PHP302 - Systematic Review and Network Meta-Analysis (Nma) in Reimbursement Submission; What Nice Says Versus what Nice Wants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.